The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

The Food and Drug Administration approved the first injectable HIV prevention medication, which could be a massive step forward in ending the long-term epidemic.

The United States Preventive Services Task Force (USPSTF), an independent panel of experts that makes recommendations on services like screenings, states that men over 70 years old should not be ...

T he U.S. Preventive Services Task Force suggests doctors not test men over 70, given the risks associated with cancer treatment and the likelihood an individual of that age will die from other ...

In 2012, the US Preventive Services Task Force recommended against PSA-based screening for prostate cancer in men of all ages. The task force reversed the recommendation in 2017, advising against ...

Prostate cancer screening guidelines from the U.S. Preventive Services Task Force, last updated in 2018, says men ages 70 and older should not get routine prostate cancer screening.

The United States Preventive Services Task Force (USPSTF), an independent panel of experts that makes recommendations on services like screenings, states that men over 70 years old should not be ...

Annual PSA screening after the age of 70 is not universally recommended. The US Preventive Services Task Force advises against it, reasoning that the risk of false positives and the harms from ...

In 2012, the U.S. Preventive Services Task Force recommended against PSA-based screening for prostate cancer in men of all ages. The task force reversed the recommendation in 2017, advising ...

The influential U.S. Preventive Services Task Force recommends men aged 55 to 69 years at typical risk decide whether to screen for prostate cancer with a PSA test.

Methods. We reviewed the United States Preventive Services Task Force (USPSTF) clinical practice guidelines to identify clinic-based low-value cancer screening practices.17 The USPSTF assigns each ...